Deerfield Healthcare Innovations Fund, L.P.

• NEW YORK, NY • Private Equity

How do I update this listing?

Create Email Alert

Deerfield Healthcare Innovations Fund is based out of New York. The firm last filed a Form D notice of exempt offering of securities on 2015-07-28. The filing was for a pooled investment fund: private equity fund The notice included securities offered of Pooled Investment Fund Interests

Contact Info

deerfield healthcare innovations fund, l.p.
780 THIRD AVENUE
NEW YORK NY 10017
Business Phone: 212-551-1600

SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Insider Information

Editas Medicine Inc - >10% Owner (02/08/2016)
Homology Medicines Inc - >10% Owner (01/29/2020)
Mirum Pharmaceuticals Inc - >10% Owner (06/06/2022)
Larimar Therapeutics Inc - Director (09/16/2022)
NUVEL HOLDINGS, INC. COMMON STOCK - Director (07/28/2021)
Oncorus Inc - >10% Owner (12/28/2022)
CalciMedica Inc - >10% Owner (09/29/2020)
Nuvalent Inc - Director (11/03/2022)

Recent SEC Filings

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Form D Filings

Form D is a form used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date	Form Type	Industry Group	Securities Offered	Total Offering Amount	Total Amount Sold	Total Remaining
2015-07-28	D	POOLED INVESTMENT FUND: PRIVATE EQUITY FUND	Pooled Investment Fund Interests	550,000,000	550,000,000	0

Other Issuers in Filings
Name	Address
No Other Issuers

Related Parties included in filings
Name	Address	Relationship
N/A DEERFIELD MGMT HIF, L.P.	subscription required	EXECUTIVE OFFICER
N/A J.E. FLYNN CAPITAL HIF, LLC	subscription required	EXECUTIVE OFFICER
JAMES E. FLYNN	subscription required	EXECUTIVE OFFICER